Abstract
Introduction
The cytoplasmic signal adaptor protein designated sequestosome1 (SQSTM1) [1] (A170 in mouse [2] , ZIP in rat [3] or p62 in human beings [4] 
) plays a key role in modulating signal transduction via membrane receptors. It interacts with different protein kinases, such as tyrosine kinase p56
lck [4] and PKC- [3] , and with other types of adaptors such as RIP [5] and TRAF6 [6] . SQSTM1 has a UBA ubiquitin-binding domain in the C-terminus [7] and participates in the assembly of ubiquitinated protein aggregates termed sequestosome [8] and modulation of ubiquitination pathways involved in NF-B activity and receptor trafficking [6] . SQSTM1 gene-targeted knockout (KO) mice exhibited matureonset obesity and insulin resistance [9] , providing a unique model to study the molecular mechanisms underlying endothelial and smooth muscle dysfunction in obesity and insulin resistance. We previously reported that SQSTM1/A170 is an oxidative stress-or electrophile-inducible protein [2] , regulated by the redox sensitive transcription factor NF-E2-related factor 2 (Nrf2) [2, 10, 11] [11] , an n-6 polyunsaturated fatty acid oxidation product detected in atherosclerotic lesions [12] . In human umbilical vein endothelial cells, expression of sqstm1 gene is up-regulated by shear stress [13] . Thus SQSTM1 may act as a novel regulator of both antioxidant and anti-inflammatory signalling pathways in the vasculature.
The aim of the present study was to determine whether SQSTM1 confers protection against vascular injury in vivo and, if so, whether SQSTM1-deficient mice exhibit alterations in vascular SMC proliferation. We examined the effects of vascular injury in wild-type (WT) and SQSTM1
-/-mice by ligating the common carotid artery [14] . Complete ligation of the vessel near the carotid bifurcation induced rapid proliferation of medial SMCs, leading to extensive neointimal formation [14] . It has previously been reported that selectins, inflammatory cytokines [15] and p38 MAPK [16] [17] [18] [19] [20] 
epidermal growth factor (EGF; 5-100 ng/ml), nerve growth factor (NGF; 5-100 ng/ml), angiotensin II (10-150 ng/ml), insulinlike growth factor (IGF; 5-100 ng/ml) and insulin (5-100 ng/ml) to the serum-deprived cultures hardly enhanced BrdU incorporation in both WT and SQSTM1 -/-SMCs (data not shown).
Interestingly, expression levels of SQSTM1 were quite low in WT SMCs seeded in fresh medium at low cell density and then gradually increased with time in culture and increased with cell density (Fig. 3D , same culture conditions as in Fig. 3A) . (Fig. 3E, same conditions as in Fig. 5A ).
Exposure of serum starved WT SMCs to 10% FCS induced rapid (0.25-1 hrs) decrease of SQSTM1 expression, and a gradual recovery after 3-6 hrs

Enhanced migration of SMCs from SQSTM1 -/-mice
SMCs migrated much faster from aortic tissue pieces from SQSTM1 -/-compared to WT mice. Moreover, using a scratch wound assay, we observed that migration of SMCs in response to 10% FCS was enhanced in cultures from SQSTM1 -/-compared to
Fig. 2 Morphometric analysis of carotid artery neointimal thickening and remodelling in WT and SQSTM1-deficient mice after 3 weeks of ligation. (A) Vessel size (inside of EEL (a) area or calculated from perimeter of (a) in case of non-ligated flat artery); (B) medial area ((a) -(b)); (C) intimal area ((b) -(c)); (D), stenotic ratio ([(b) -(c)]/(b)). Values are means Ϯ S.E. of measurements in tissue sections from WT (non-ligated left artery, n ϭ 16; ligated right artery, n ϭ 13) and SQSTM1-deficient (non-ligated left artery, n ϭ 11; ligated right artery, n ϭ 11) mice. *P Ͻ 0.05, ***P Ͻ 0.005, between non-ligated and ligated (A and B) or WT and SQSTM1 -/-mice (C and D).
WT mice (Fig. 4) (Fig. 6A) . A JNK inhibitor (SP: SP600125, 1 and 2 M) had no effect on BrdU incorporation in either WT or SQSTM1 -/-SMCs (Fig. 6A ).
Because tyrosine kinases play an integral role in serum stimulated MAPK activation [28] , we examined the effect of the general tyrosine kinase inhibitor genistein and the EGF receptor targeted tyrosine kinase inhibitor PD153035 [29] on BrdU incorporation. We found that 1 and 5 M PD153035 and 50 M genistein significantly reduced elevated BrdU incorporation in SQSTM1 -/-SMCs (Fig. 6B) .
Discussion
This study provides the first evidence in vivo that the signal adaptor protein SQSTM1 plays a fundamental role in attenuating 
